cutaneous leishmaniasis (cl) is an endemic disease in iran that is caused by leishmania parasite and transmits to human by phelebotumus sand flies. the lysis of the skin cells occurs by the parasite with the presentation of a dry sore in the rural areas and a wet sore in the urban areas. in this study, the frequency and epidemiologic parameters of cutaneous leishmaniasis patients were studied i...

abstract background glucantime is the first line agent for treatment of cutaneous leishmaniasis (cl). it has adverse effects on blood elements. this research has been done to evaluate the blood complications of this medicine in patients with cutaneous leishmaniasis. methods this clinical trial was done at nikpour clinic, yazd, iran. blood samples were collected from patients diagnosed with cl b...

background: cutaneous leishmaniasis is an endemic disease in many regions of iran, including the city of mashhad. in recent years, some cases have not responded to glucantime, the usual treatment for this disease. the cellular immune response caused by t-helper type 1 (th1) cells has an important role in protection against leishmaniasis, and activation of the t-helper type 2 (th2) response caus...

was present. The glands of the neck were enlarged. On enquiry I was told that she had never been out of Calcutta, and I gave instructions that I would see the case again a fortnight later. She was again brought to me on the 20th December, 1924. By this time the sore had increased considerably in size, and there was a very marked scab. I punctured the edge of the sore and found Leishmania tropic...

More than 90% of patients infected with cutaneous leishmaniasis live in Afghanistan, the Middle East, Algeria, Brazil, and Peru. Cutaneous leishmaniasis in Iran is caused by Leishmania tropica and Leishmania major. Most skin lesions evolve from papular to nodular, to ulcerative form with a central depression surrounded by a raised indurate border. Some lesions persist as nodules or plaques. Mul...

background: leishmaniasis, especially cutaneous leishmaniasis, is considered an important health problem in many parts of iran including kharve, khorasan razavi province. cutaneous leishmaniasis is caused by various species of leishmania, each having a different secondary host. thus, identifying the parasites’ specie is of paramount importance for containment strategy planning. the morphologica...

Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where in the world HIV/VL coinfection has become endemic. The case here suffers from both AIDS and visceral-cutaneous leishmaniasis. We report an Ira...

the aim of this study was to measure the alterations in serum zinc (zn) copper (cu) and iron (fe) concentrations in patients with acute and chronic cutaneous leishmaniasis. serum zinc and copper were measured by flameless atomic absorption spectrophotometer and serum iron concentration was measured by the ferrozine method with commercial kits and assay was carried out by using an automatic anal...

cutaneous leishmaniasis may present with clinical presentation such as zosteriform, sporotrichoid and erysipeloid. the eczema variant has rarely been reported. we report a 27- year- old patient with atypical cutaneous leishmaniasis resembling eczema on the hand of a man in yazd province in the central of iran.

American cutaneous leishmaniasis acquired epidemic characteristics on the northern coastline of the State of São Paulo beginning in the 1990s. From secondary data, a descriptive study of the disease in the four municipalities making up this region over the period from 1993 to 2005 was conducted. The frequency of phlebotomine capture in the probable transmission locations was analyzed. 689 autoc...